Cross-sectional Study to Investigate the Effects of Chronic Obstructive Pulmonary Disease on Daily Life Activities
COPD LIFE
Cross-sectional Observational Study to Investigate the Effects of Chronic Obstructive Pulmonary Disease on Daily Life Activities
1 other identifier
observational
497
1 country
20
Brief Summary
The purpose of this study is to investigate the effects of Chronic Obstructive Pulmonary Disease (COPD) on daily life activities in patients with COPD and also to determine the socio-demographic profile, daily life style and needs of the patients with COPD.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2011
Shorter than P25 for all trials
20 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2011
CompletedFirst Submitted
Initial submission to the registry
March 21, 2011
CompletedFirst Posted
Study publicly available on registry
March 30, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2011
CompletedJuly 21, 2011
July 1, 2011
3 months
March 21, 2011
July 20, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Effect of COPD on daily activities
The distribution of the patients according to their answers, as Yes / No / Unknown, given to the questions of patient questionnaire about the effect of COPD on daily life and which daily activities are limited will be calculated as percentage.
1 year
Secondary Outcomes (1)
Patients' socio-demographic profiles, daily life conditions and needs and expectations from therapy
Baseline
Study Arms (1)
Patients with COPD
Eligibility Criteria
Outpatients from health institutions where the patients with COPD are treated
You may qualify if:
- Diagnosis of COPD
- Outpatient treatment for any reason
- Current or ex-smoker
You may not qualify if:
- An exacerbation of COPD that still lasts or that was experienced within last 3 months
- History of asthma and/or allergic rhinitis
- The presence of another important respiratory disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- AstraZenecalead
Study Sites (20)
Research Site
Adana, Turkey (Türkiye)
Research Site
Ankara, Turkey (Türkiye)
Research Site
Antalya, Turkey (Türkiye)
Research Site
Aydin, Turkey (Türkiye)
Research Site
Bartın, Turkey (Türkiye)
Research Site
Bolu, Turkey (Türkiye)
Research Site
Burdur, Turkey (Türkiye)
Research Site
Bursa, Turkey (Türkiye)
Research Site
Gaziantep, Turkey (Türkiye)
Research Site
Gebze, Turkey (Türkiye)
Research Site
Giresun, Turkey (Türkiye)
Research Site
Isparta, Turkey (Türkiye)
Research Site
Istanbul, Turkey (Türkiye)
Research Site
Izmir, Turkey (Türkiye)
Research Site
Karabük, Turkey (Türkiye)
Research Site
Kayseri, Turkey (Türkiye)
Research Site
Konya, Turkey (Türkiye)
Research Site
Manisa, Turkey (Türkiye)
Research Site
Mersin, Turkey (Türkiye)
Research Site
Yozgat, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Zeynep Goztas
AstraZeneca Turkey
- PRINCIPAL INVESTIGATOR
Mehmet Polatli
Adnan Menderes University Faculty of Medicine
Study Design
- Study Type
- observational
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
March 21, 2011
First Posted
March 30, 2011
Study Start
March 1, 2011
Primary Completion
June 1, 2011
Study Completion
June 1, 2011
Last Updated
July 21, 2011
Record last verified: 2011-07